USD 1.0
(-4.76%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 89.76 USD | -99.82% |
2023 | 49.06 Thousand USD | -94.0% |
2022 | 817.92 Thousand USD | -62.83% |
2021 | 2.2 Million USD | 517.17% |
2020 | 356.55 Thousand USD | 16293.29% |
2019 | 2175.00 USD | 0.0% |
2018 | 2175.00 USD | 0.0% |
2014 | 251.9 Thousand USD | 2943.41% |
2013 | 8277.00 USD | 2687237.66% |
2012 | 0.31 USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 2214.00 USD | -67.26% |
2024 Q3 | 6503.00 USD | 193.72% |
2024 Q4 | 74.23 Thousand USD | 1041.49% |
2024 Q1 | 6763.00 USD | 146.25% |
2024 FY | 89.75 Thousand USD | 82.94% |
2023 Q1 | 49.67 Thousand USD | -78.39% |
2023 Q2 | -1452.00 USD | -102.92% |
2023 Q4 | -14.62 Thousand USD | -324.71% |
2023 FY | 49.06 Thousand USD | -94.0% |
2023 Q3 | 6508.00 USD | 548.21% |
2022 Q4 | 229.86 Thousand USD | 536.0% |
2022 FY | 817.92 Thousand USD | -62.83% |
2022 Q3 | -52.72 Thousand USD | -129.85% |
2022 Q2 | 176.63 Thousand USD | -61.94% |
2022 Q1 | 464.14 Thousand USD | -32.25% |
2021 FY | 2.2 Million USD | 517.17% |
2021 Q4 | 685.12 Thousand USD | 21.34% |
2021 Q3 | 564.62 Thousand USD | -10.26% |
2021 Q1 | 321.63 Thousand USD | 140.83% |
2021 Q2 | 629.17 Thousand USD | 95.62% |
2020 Q2 | 11.7 Thousand USD | -35.61% |
2020 FY | 356.55 Thousand USD | 16293.29% |
2020 Q4 | 133.55 Thousand USD | -31.43% |
2020 Q3 | 194.76 Thousand USD | 1563.82% |
2020 Q1 | 18.18 Thousand USD | 0.0% |
2019 FY | 2175.00 USD | 0.0% |
2018 FY | 2175.00 USD | 0.0% |
2015 Q2 | 750.28 Thousand USD | -34.36% |
2015 Q1 | 1.14 Million USD | 371.48% |
2015 Q3 | 881.65 Thousand USD | 17.51% |
2014 Q4 | 242.44 Thousand USD | 20728.26% |
2014 FY | 251.9 Thousand USD | 2943.41% |
2014 Q3 | 1164.00 USD | -64.23% |
2014 Q2 | 3254.00 USD | -35.49% |
2014 Q1 | 5044.00 USD | 112.83% |
2013 Q4 | 2370.00 USD | -0.29% |
2013 Q3 | 2377.00 USD | -27.35% |
2013 Q2 | 3272.00 USD | 1163.32% |
2013 FY | 8277.00 USD | 2687237.66% |
2013 Q1 | 259.00 USD | 113496.49% |
2012 Q4 | 0.23 USD | 0.0% |
2012 FY | 0.31 USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 238.36 Thousand USD | 99.962% |
Instadose Pharma Corp. | - USD | -Infinity% |